GU Cancers Symposium 2014 - Impact of prior radiation treatment on sipuleucel-T product parameters in PROCEED patients - Poster

SAN FRANCISCO, CA USA ( - Presented by Steven E. Finkelstein, Luke T. Nordquist, Shaker R. Dakhil, Nathan B. Green, Elisabeth I. Heath, Ronald Tutrone, Nicholas J. Vogelzang, Andrew J. Armstrong, Matthew R. Cooperberg, Robert Claude Tyler, Robert Brownell Sims, James Boyd Whitmore, and Celestia S. Higano at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 Finkelstein Sip-T thumb


21st Century Oncology, Translational Research Consortium, Scottsdale, AZ; Oncology Hematology West PC, Omaha, NE; Cancer Center of Kansas, Wichita, KS; Southeast Nebraska Hem and Onc Consult PC, Lincoln, NE; Karmanos Cancer Institute/Wayne State University, Detroit, MI; Chesapeake Urologic Research Associates, Baltimore, MD; Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Duke University, Durham, NC; University of California, San Francisco, San Francisco, CA; Dendreon Corporation, Seattle, WA; University of Washington/Seattle Cancer Care Alliance, Seattle, WA